BAKER BROS ADVISORS LLC Insider Trading $SGEN Seagen Inc.
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and in XOMA Corp ($XOMA) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in Zymeworks Inc. ($ZYME) and Director in Kodiak Sciences Inc. ($KOD) and 10% Owner in Invitae Corp ($NVTA) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Atreca, Inc. ($BCEL) and in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and Director in Talis Biomedical Corp ($TLIS) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in Intellia Therapeutics, Inc. ($NTLA) and Director in BeiGene, Ltd. ($BGNE) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in HOOKIPA Pharma Inc. ($HOOK).
BAKER BROS ADVISORS LLC in Seagen Inc.
Trading Symbol: SGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 4,082,851 shares
Current Value: $248,196,512
Latest Transaction: May 19 2020
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC in Seagen Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, AGLE, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, IGMS, INCY, NTLA, NVTA, KNSA, KOD, MYG, NLTX, PRLD, RYTM, SGEN, TLIS, XOMA, ZYME
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 19 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 160.33 | 3,171 | 508,406 | 3,171 | |
May 19 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,335 | 0 | 43,290,171 | 43.3 M to 43.3 M (0.00 %) |
May 19 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,335 | 0 | 4,084,186 | 4.1 M to 4.1 M (+0.03 %) |
May 19 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 160.00 | 1,602,312 | 256,369,920 | 43,288,836 | 44.9 M to 43.3 M (-3.57 %) |
May 19 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 160.00 | 147,688 | 23,630,080 | 4,082,851 | 4.2 M to 4.1 M (-3.49 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 158.50 | 457,803 | 72,561,776 | 44,891,148 | 45.3 M to 44.9 M (-1.01 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 158.50 | 42,197 | 6,688,225 | 4,230,539 | 4.3 M to 4.2 M (-0.99 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 166.16 | 4,343 | 721,610 | 45,348,951 | 45.4 M to 45.3 M (-0.01 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 166.16 | 400 | 66,462 | 4,272,736 | 4.3 M to 4.3 M (-0.01 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 164.96 | 48,880 | 8,063,118 | 45,353,294 | 45.4 M to 45.4 M (-0.11 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 164.96 | 4,505 | 743,133 | 4,273,136 | 4.3 M to 4.3 M (-0.11 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 164.19 | 84,663 | 13,901,157 | 45,402,174 | 45.5 M to 45.4 M (-0.19 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 164.19 | 7,805 | 1,281,534 | 4,277,641 | 4.3 M to 4.3 M (-0.18 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 163.41 | 16,159 | 2,640,610 | 45,486,837 | 45.5 M to 45.5 M (-0.04 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 163.41 | 1,489 | 243,324 | 4,285,446 | 4.3 M to 4.3 M (-0.03 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 166.62 | 41,072 | 6,843,564 | 45,502,996 | 45.5 M to 45.5 M (-0.09 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 166.62 | 3,786 | 630,837 | 4,286,935 | 4.3 M to 4.3 M (-0.09 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 165.70 | 91,613 | 15,180,641 | 45,544,068 | 45.6 M to 45.5 M (-0.20 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 165.70 | 8,444 | 1,399,205 | 4,290,721 | 4.3 M to 4.3 M (-0.20 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 164.60 | 178,862 | 29,440,041 | 45,635,681 | 45.8 M to 45.6 M (-0.39 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 164.60 | 16,485 | 2,713,372 | 4,299,165 | 4.3 M to 4.3 M (-0.38 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 164.06 | 45,606 | 7,482,107 | 45,814,543 | 45.9 M to 45.8 M (-0.10 %) |
May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 164.06 | 4,204 | 689,707 | 4,315,650 | 4.3 M to 4.3 M (-0.10 %) |
Apr 24 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 12.76 | 17,500 | 223,300 | 0 | |
Apr 24 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 12.76 | 17,500 | 223,300 | 0 | |
Apr 24 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 12.76 | 17,500 | 223,300 | 45,860,149 | 45.8 M to 45.9 M (+0.04 %) |
Apr 24 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 12.76 | 17,500 | 223,300 | 4,319,854 | 4.3 M to 4.3 M (+0.41 %) |
Jun 07 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 74,229 | 0 | 181,733 | 107.5 K to 181.7 K (+69.05 %) |
Jun 07 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 74,229 | 0 | 181,740 | 107.5 K to 181.7 K (+69.04 %) |
Jun 07 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | J | 0.00 | 1,002,483 | 0 | 4,302,354 | 5.3 M to 4.3 M (-18.90 %) |
May 22 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
May 22 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
May 22 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 2,963 | 0 | 45,842,649 | 45.8 M to 45.8 M (+0.01 %) |
May 22 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 2,963 | 0 | 5,304,837 | 5.3 M to 5.3 M (+0.06 %) |
May 01 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 8.38 | 10,000 | 83,800 | 0 | |
May 01 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 8.38 | 10,000 | 83,800 | 0 | |
May 01 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 8.38 | 10,000 | 83,800 | 45,839,686 | 45.8 M to 45.8 M (+0.02 %) |
May 01 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 8.38 | 10,000 | 83,800 | 5,301,874 | 5.3 M to 5.3 M (+0.19 %) |
May 18 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
May 18 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
May 18 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 56.77 | 3,700 | 210,049 | 45,829,686 | 45.8 M to 45.8 M (+0.01 %) |
May 18 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 56.77 | 3,700 | 210,049 | 5,291,874 | 5.3 M to 5.3 M (+0.07 %) |
May 08 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 54.02 | 126,399 | 6,828,339 | 45,825,986 | 45.7 M to 45.8 M (+0.28 %) |
May 08 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 53.70 | 129,715 | 6,966,305 | 45,699,587 | 45.6 M to 45.7 M (+0.28 %) |
May 08 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.68 | 204,537 | 10,775,582 | 45,569,872 | 45.4 M to 45.6 M (+0.45 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 10.08 | 10,000 | 100,800 | 0 | |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 10.08 | 10,000 | 100,800 | 0 | |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 54.42 | 9,105 | 495,488 | 45,365,335 | 45.4 M to 45.4 M (+0.02 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.26 | 21,442 | 1,120,576 | 45,356,230 | 45.3 M to 45.4 M (+0.05 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.33 | 37,400 | 1,957,022 | 45,334,788 | 45.3 M to 45.3 M (+0.08 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.88 | 2,000 | 103,750 | 45,297,388 | 45.3 M to 45.3 M (0.00 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.33 | 5,951 | 311,418 | 45,295,388 | 45.3 M to 45.3 M (+0.01 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.06 | 37,963 | 1,976,213 | 45,289,437 | 45.3 M to 45.3 M (+0.08 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.37 | 57,270 | 2,941,708 | 45,251,474 | 45.2 M to 45.3 M (+0.13 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.36 | 10,500 | 539,280 | 45,194,204 | 45.2 M to 45.2 M (+0.02 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.30 | 22,700 | 1,164,424 | 45,183,704 | 45.2 M to 45.2 M (+0.05 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.26 | 72,533 | 3,717,693 | 45,161,004 | 45.1 M to 45.2 M (+0.16 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.14 | 100,000 | 5,114,000 | 45,088,471 | 45 M to 45.1 M (+0.22 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 10.08 | 10,000 | 100,800 | 44,988,471 | 45 M to 45 M (+0.02 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 10.08 | 10,000 | 100,800 | 5,288,174 | 5.3 M to 5.3 M (+0.19 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.25 | 168,097 | 8,614,786 | 44,978,471 | 44.8 M to 45 M (+0.38 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.07 | 52,700 | 2,691,173 | 44,810,374 | 44.8 M to 44.8 M (+0.12 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.03 | 248,121 | 12,661,069 | 44,757,674 | 44.5 M to 44.8 M (+0.56 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 50.90 | 154,218 | 7,849,897 | 44,509,553 | 44.4 M to 44.5 M (+0.35 %) |
Feb 05 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.00 | 3,456,543 | 179,740,236 | 44,355,335 | 40.9 M to 44.4 M (+8.45 %) |
Feb 05 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.00 | 389,610 | 20,259,720 | 5,278,174 | 4.9 M to 5.3 M (+7.97 %) |
May 23 2017 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 66.60 | 9,260 | 616,716 | 9,260 | |
May 23 2017 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 66.60 | 9,260 | 616,716 | 9,260 | |
May 23 2017 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 66.60 | 3,700 | 246,420 | 40,898,792 | 40.9 M to 40.9 M (+0.01 %) |
May 23 2017 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 66.60 | 3,700 | 246,420 | 4,888,564 | 4.9 M to 4.9 M (+0.08 %) |
May 17 2017 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 10.20 | 10,000 | 102,000 | 0 | |
May 17 2017 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 10.20 | 10,000 | 102,000 | 0 | |
May 17 2017 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 10.20 | 10,000 | 102,000 | 40,895,092 | 40.9 M to 40.9 M (+0.02 %) |
May 17 2017 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 10.20 | 10,000 | 102,000 | 4,884,864 | 4.9 M to 4.9 M (+0.21 %) |
Page: 1